ResMed Inc. Health Care
Medical Sleep Apnea Software

$32.81 0.28 (0.86%)

High $32.86	Low $32.55	Trades 6,994	Turnover $36,021,783	Volume 1,098,777
30 June 2023 at 4:12pm

Market Cap (3-Aug) $43,894,063,104 (13th)	Close (30-Jun) $32.81 0 (0%)	Volume (30-Jun) 1,098,777	Shortsold (28-Jul) 1,849,819 (0.31%) (367th)
52w High $44.92	52w Low $25.50	P/E 17.79	EPS 1.49
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 1+

Short Interest

ASIC data, 28 Jul 2026

% Shorted

0.31% 0.05

vs 0.36% prior report

Most Shorted Rank

367th

of 710 shorted ASX stocks

Peak Short

3.10%

Oct 2014

Days to Cover

0.9

at 50d avg vol

View full short position history →

	Subject
	RMD Article: ‘Could be next Cochlear or ResMed’: heart device maker wins FDA approval
	1 (current) 2 3
	RMD Article: Sleep device giant ResMed says Trump tariffs will boost profits
	RMD Article: ResMed downplays Ozempic disruption fears as sales beat forecasts
	RMD Article: ResMed says sales growth defies weight-loss fears
	RMD Article: ASX to dive, ResMed ups dividend; Macquarie eyes hybrid issue
	RMD Article: ASX to dive, ResMed ups dividend; Block upgrades guidance
	RMD Article: Who are the highest paid ASX 200 CEOs?
	RMD Article: ASX gains, Collins Foods leaps 9pc, Paladin tumbles
	RMD Article: ResMed sinks as drug trial sparks Ozempic-style sell-off
	RMD Article: How Sage Capital is making money from other investors’ panic
	RMD Article: ASX stocks at risk from Ozempic – and ResMed isn’t one of them
	RMD Article: ASX to rise; Sayona cuts staff, Domino’s revokes guidance
	RMD Article: ASX charts fifth session of gains, led by miners; Domino’s sinks 30pc
	RMD Article: Why Australia’s biggest and oldest LIC defied the Ozempic sell-off
	RMD Article: Hedge fund LHC buys ResMed, bets against sceptics
	RMD Article: This fundie is betting against the ResMed sceptics
	RMD Article: Why Chris Kourtis just bought CSL and ResMed
	RMD Article: Beware of the Ozempic hype and its irrational market outcomes
	RMD Article: Unloved healthcare stocks can reinvent themselves
	RMD Article: Obesity drug sell-offs based on ‘guess work’
	RMD Article: ASX falls; Star sinks 15pc; ResMed jumps on Goldman report
	RMD Article: Why Hamish Tadgell just bought back into ResMed
	RMD Article: Why Hamish Tadgell just bought back into ResMed
	RMD Article: Why the Ozempic revolution matters to ASX investors
	RMD Article: ASX to slip; UBS cuts ResMed outlook; Macquarie flags 1Q24 hit
	RMD Article: ResMed short sellers see an opportunity with the rise of Ozempic
	RMD Article: ASX rallies to close higher; CBA buoys big four; Suncorp, ResMed sink
	RMD Article: You’re probably paying too much for CBA and CSL stocks
	RMD Article: ASX falls; Resmed, Suncorp, Block shares tumble
	RMD Article: ASX closes higher but ends the week down 1pc
	RMD Article: ASX ends the session higher but posts first weekly loss in four
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM SD
	RMD Ann: Update - Dividend/Distribution - RMD
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM 10Q for Qtr ended March, 2023
	RMD Article: How fewer smartphone shipments boosted ResMed’s sales
	RMD Ann: Dividend/Distribution - RMD
	RMD Ann: ResMed Announces Results for the Third Quarter of FY2023
	RMD Ann: RMD to Report Third Quarter Fiscal 2023 Results
	RMD Article: ResMed among Goldman’s picks if US economy falters
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: Company Secretary Appointment/Resignation
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: Update - Dividend/Distribution - RMD
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM 10Q for Qtr ended December, 2022
	RMD Article: ResMed hits $1.4b in quarterly revenue
	RMD Ann: Dividend/Distribution - RMD
	RMD Ann: Chairman Appointment/Resignation

End of Day Prices

Date	Close	Volume	Change
03-Aug	$30.26	3,014,046	+0.47 (1.58%)
31-Jul	$29.79	925,731	-0.46 (1.52%)
30-Jul	$30.25	3,144,753	+0.26 (0.87%)
29-Jul	$29.99	1,902,557	+1.04 (3.59%)
28-Jul	$28.95	1,628,091	+0.95 (3.39%)
27-Jul	$28.00	997,670	+0.57 (2.08%)
24-Jul	$27.43	850,529	-0.11 (0.40%)
23-Jul	$27.54	2,011,624	-0.21 (0.76%)
22-Jul	$27.75	2,475,095	-0.19 (0.68%)
21-Jul	$27.94	1,536,985	-0.25 (0.89%)
20-Jul	$28.19	855,646	-0.56 (1.95%)
17-Jul	$28.75	873,233	-12.19 (29.78%)
18-Sep	$40.94	809,879	-0.31 (0.75%)
12-Sep	$41.25	834,948	+0.12 (0.29%)
11-Sep	$41.13	1,778,501	-1.13 (2.67%)
6 up, 9 down, and 0 flat days

ResMed Inc. Health Care Medical Sleep Apnea Software

Short Interest

Followers

Prices

Announcements

End of Day Prices

ResMed Inc. Health Care
Medical Sleep Apnea Software